Cargando…

Serious infection risk of tofacitinib compared to biologics in patients with rheumatoid arthritis treated in routine clinical care

Recently, serious infections related to the use of tofacitinib (TOF) for treatment of rheumatoid arthritis (RA) have raised considerable interest. This study aimed to compare the risk for serious infections in patients with RA upon receiving TOF versus biologic disease-modifying antirheumatic drugs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Riek, Myriam, Scherer, Almut, Möller, Burkhard, Ciurea, Adrian, von Mühlenen, Ines, Gabay, Cem, Kyburz, Diego, Brulhart, Laure, von Kempis, Johannes, Mueller, Ruediger B., Hasler, Paul, Strahm, Tanja, von Känel, Sabine, Zufferey, Pascal, Dudler, Jean, Finckh, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584888/ https://www.ncbi.nlm.nih.gov/pubmed/37853058 http://dx.doi.org/10.1038/s41598-023-44841-w

Ejemplares similares

Comparative effectiveness of antitumour necrosis factor agents, biologics with an alternative mode of action and tofacitinib in an observational cohort of patients with rheumatoid arthritis in Switzerland
por: Finckh, A, et al.
Publicado: (2020)

Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists
por: Finckh, Axel, et al.
Publicado: (2012)

Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
por: Finckh, A, et al.
Publicado: (2010)

NLRP3 Q703K and TNFRSF1A R92Q mutations in a patient with auto inflammatory disease
por: von Mühlenen, I, et al.
Publicado: (2015)

Change from subcutaneous to intravenous abatacept and back in patients with rheumatoid arthritis as simulation of a vacation: a prospective phase IV, open-label trial (A-BREAK)
por: Mueller, Ruediger B., et al.
Publicado: (2016)

Does tenosynovitis of the hand detected by B-mode ultrasound predict loss of clinical remission in rheumatoid arthritis? Results from a real-life cohort
por: Micheroli, Raphael, et al.
Publicado: (2022)

Effectiveness, Tolerability, and Safety of Tofacitinib in Rheumatoid Arthritis: A Retrospective Analysis of Real-World Data from the St. Gallen and Aarau Cohorts
por: Mueller, Ruediger B., et al.
Publicado: (2019)

Ultrasound is not associated with the presence of systemic autoimmunity or symptoms in individuals at risk for rheumatoid arthritis
por: Brulhart, Laure, et al.
Publicado: (2019)

Type of mRNA COVID-19 vaccine and immunomodulatory treatment influence humoral immunogenicity in patients with inflammatory rheumatic diseases
por: Raptis, Catherine E., et al.
Publicado: (2022)

Comparison of drug survival on adalimumab, etanercept, golimumab and infliximab in patients with axial spondyloarthritis
por: Hebeisen, Monika, et al.
Publicado: (2019)

Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
por: Mueller, Ruediger B., et al.
Publicado: (2022)

Anaemia may add information to standardised disease activity assessment to predict radiographic damage in rheumatoid arthritis: a prospective cohort study
por: Möller, Burkhard, et al.
Publicado: (2014)

Synovitis in rheumatoid arthritis detected by grey scale ultrasound predicts the development of erosions over the next three years
por: Möller, Burkhard, et al.
Publicado: (2020)

Anaemia is associated with higher disease activity in axial spondyloarthritis but is not an independent predictor of spinal radiographic progression: data from the Swiss Clinical Quality Management Registry
por: Micheroli, Raphael, et al.
Publicado: (2023)

Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
por: Micheroli, Raphael, et al.
Publicado: (2017)

Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors
por: Nissen, Michael J., et al.
Publicado: (2021)

A 56 year old woman with clinically significant p.Arg121Gln-/R92Q TNFRSF1A mutation
por: von Mühlenen, I, et al.
Publicado: (2015)

The role of unique color changes and singletons in attention capture
por: von Mühlenen, Adrian, et al.
Publicado: (2016)

Attention capture by abrupt onsets: re-visiting the priority tag model
por: Sunny, Meera M., et al.
Publicado: (2013)

A systematic review of infliximab in the treatment of early rheumatoid arthritis
por: Du Pan, Sophie Martin, et al.
Publicado: (2007)

Superiority of a Treat-to-Target Strategy over Conventional Treatment with Fixed csDMARD and Corticosteroids: A Multi-Center Randomized Controlled Trial in RA Patients with an Inadequate Response to Conventional Synthetic DMARDs, and New Therapy with Certolizumab Pegol
por: Mueller, Ruediger B., et al.
Publicado: (2019)

Early axial spondyloarthritis according to the ASAS consensus definition: characterisation of patients and effectiveness of a first TNF inhibitor in a large observational registry
por: Ciurea, Adrian, et al.
Publicado: (2023)

HLA-B27 as a predictor of effectiveness of treatment with TNF inhibitors in axial spondyloarthritis: data from the Swiss Clinical Quality Management Registry
por: Fröhlich, Fabienne, et al.
Publicado: (2022)

Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort
por: Hebeisen, Monika, et al.
Publicado: (2020)

Impact of assessing patient-reported outcomes with mobile apps on patient–provider interaction
por: Shaw, Yomei, et al.
Publicado: (2021)

Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort
por: Ciurea, Adrian, et al.
Publicado: (2022)

Clinical and radiographic course of early undifferentiated arthritis under treatment is not dependent on the number of joints with erosions at diagnosis: results from the Swiss prospective observational cohort
por: Mueller, Ruediger B, et al.
Publicado: (2018)

Diagnostic value of anti-cyclic citrullinated peptides and association with HLA-DRB1 shared epitope alleles in African rheumatoid arthritis patients
por: Singwe-Ngandeu, Madeleine, et al.
Publicado: (2010)

Here Today, Gone Tomorrow – Adaptation to Change in Memory-Guided Visual Search
por: Zellin, Martina, et al.
Publicado: (2013)

Anti-SARS-CoV-2 mRNA vaccine in patients with rheumatoid arthritis
por: Rubbert-Roth, Andrea, et al.
Publicado: (2021)

Characterisation of patients with axial psoriatic arthritis and patients with axial spondyloarthritis and concomitant psoriasis in the SCQM registry
por: Ciurea, Adrian, et al.
Publicado: (2023)

Clinical Images: Hydroxychloroquine‐associated mucous labial pigmentation in a patient with systemic lupus erythematosus improving under topical treatment with tacrolimus
por: Pirker, Ian, et al.
Publicado: (2021)

Clinical Image: In vivo urate spherulites in a patient with gout
por: Pirker, Ian, et al.
Publicado: (2021)

Tofacitinib
Publicado: (2012)

Anti‐SARS‐CoV‐2 mRNA vaccines as inducers of humoral response against apolipoprotein A‐1?
por: Vuilleumier, Nicolas, et al.
Publicado: (2021)

Sacroiliac joint radiographic progression in axial spondyloarthritis is retarded by the therapeutic use of TNF inhibitors: 12-year data from the SCQM registry
por: Micheroli, Raphael, et al.
Publicado: (2022)

Taking Situatedness Seriously. Embedding Affective Intentionality in Forms of Living
por: von Maur, Imke
Publicado: (2021)

Pausing drugs and spacing vaccines: an open question – Authors' reply
por: Rubbert-Roth, Andrea, et al.
Publicado: (2021)

Frequency and Duration of Early Non-serious Adverse Events in Patients with Rheumatoid Arthritis and Psoriatic Arthritis Treated with Tofacitinib
por: Dikranian, Ara, et al.
Publicado: (2021)

Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
por: Schmiedeberg, Kristin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vd5gb8vp3dbdhvrdi5c748lsmg